Residential and commercial circuit breakers face three major challenges: detecting arc faults reliably, reducing false trips ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 3.5% Wednesday after the precision medicine technology company announced the launch of its new HRD-RNA algorithm for cancer detection.

The research began as a scientific test of whether subtle changes in pupil dilation and eye movement could reveal deception as reliably as a polygraph.

Learn more about the process known as “flags of convenience” and how they are strongly correlated with IUU fishing and labor ...

Researchers have found a new approach to finding shortest paths, but it's complex Systems Approach Last year a couple of people forwarded to me the same article on a new method of finding shortest ...

Tempus AI TEM rose on Wednesday after the company unveiled its new HRD-RNA algorithm, an AI-driven tool designed to improve detection of homologous recombination deficiency (HRD) in tumors. The ...

The positioning technology specialist rang up its first quarterly profit after years in the red, turbocharged by torrid growth across products like sensors for robots Robosense logged a profit of 60 ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsXingjuan Chao - Co-Founder, President, CEO & ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, proposed a quantum intelligent interconnected fault-tolerant consensus algorithm that deeply ...

Introduction The proliferation of deepfake technology, synthetic media generated using advanced artificial intelligence techniques, has emerged as a ...

Tempus HRD-RNA is an AI-driven, 1,660-gene logistic regression model designed to identify patients likely to respond to ...

This article examines how institutions move beyond AI hype and embed AI into operational workflows in ways that create ...